[Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. 2. Drug resistance, drug concentration in blood and side effects].
D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003967:Diarrhea / Q000139:chemically induced; D004352:Drug Resistance, Microbial; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D012293:Rifampin / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D013546:Sweating / Q000187:drug effects; D013696:Temperature; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D012293:Rifampin